Many cancer therapies produce toxic side effects whose molecular mechanisms await full
elucidation. The most feared and studied side effect of chemotherapeutic drugs is …

1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …

The risk of cardiotoxicity is the most serious drawback to the clinical usefulness of
anthracycline antineoplastic antibiotics, which include doxorubicin (adriamycin) …

Abstract Significance: Anthracyclines (doxorubicin, daunorubicin, or epirubicin) rank among
the most effective anticancer drugs, but their clinical usefulness is hampered by the risk of …

Aims Anthracycline‐induced cardiotoxicity (ACT) occurs in 57% of treated patients and
remains an important limitation of anthracycline‐based chemotherapy. In various genetic …

Anthracyclines remain among the most widely prescribed and effective anticancer agents.
Unfortunately, life-threatening cardiotoxicity continues to compromise their usefulness …

Anthracyclines (doxorubicin, daunorubicin, epirubicin, and idarubicin) are among the most
potent chemotherapeutic agents and have truly revolutionized the management of childhood …

Many methods of systemic anticancer treatment have detrimental effects on the
cardiovascular system, thus limiting the possibility of further therapy, worsening patients' …

Drug resistance is a major problem in cancer treatment, as it limits the effectiveness of
pharmacological agents and can lead to disease progression. Cold atmospheric plasma …

The Physical Activity Readiness Questionnaire (PAR-Q) and the Physical Activity Readiness
Medical Evaluation (PARmed-X) are internationally known preparticipation screening tools …